|
|
|
| Study on drug laws of Beiji Qianjin Yao Fang and Qianjin Yi Fang in the treatment of renal edema based on data mining |
| LI Xiyao1 GAO Hongjie2 SUN Luying1 BAO Wujisiguleng1 ZHANG Mingzhu1 WEI Shuguang1 |
1.Department of Nephrology and Endocrinology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China;
2.Institute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China |
|
|
|
Abstract Objective To use the data mining technology to explore and summarize the drug laws of the treatment of renal edema in Beiji Qianjin Yao Fang and Qianjin Yi Fang (hereinafter referred to as Qianjin Fang). Methods The prescriptions for treating renal edema in Qianjin Fang were selected to establish a standard medical record database, and the cloud platform of ancient and modern medical records was used to make statistics on drug frequency, drug properties, drug flavor, channel tropism, drug association rules, and cluster analysis. Results A total of 67 formulas for the treatment of renal edema from Qian Jin Fang were included in this study, involving 67 prescriptions, among which 44 were Beiji Qianjin Yao Fang and 23 were Qianjin Yi Fang. A total of 144 traditional Chinese medicine were involved, and the top three drugs with high frequency were Atractylodis Macrocephalae Rhizoma, Poria, and Cinnamomi Ramulus. The drug properties were more warm, the drug flavors were more sweet, pungent, and bitter, more return to the lung, spleen, kidney channel. The drug efficacy was more inducing diuresis for removing edema, invigorating spleen, diuresis and diffusing dampness, dispelling pathogenic wind and relieving pain, eliminating dampness and diuresis, and so on. In the association rules of the two drug patterns, the confidence of Stephaniae Tetrandrae Radix→Atractylodis Macrocephalae Rhizoma was the highest. Drugs used more than 20 times could be grouped into four groups by cluster analysis. Conclusion Through data mining, the differentiation and treatment ideas of renal edema in Qianjin Fang are shown, that is, the idea of taking deficiency and excess as the key line, sanjiao as the differentiation method and elimination as the method is formed, which provided reference for the clinical practice of traditional Chinese medicine treatment of renal edema.
|
|
|
|
|
|
[1] 谌贻璞，陈洪宇，刘宝利，等.肾性水肿的中西医结合诊断与治疗[J].中国中西医结合肾病杂志，2020，21（9）：843- 846.
[2] Kallash M，Mahan JD. Mechanisms and management of edema in pediatric nephrotic syndrome [J]. Pediatr Nephrol，2021，36（7）：1719-1730.
[3] van de Wouw J，Joles JA. Albumin is an interface between blood plasma and cell membrane，and not just a sponge[J]. Clin Kidney J，2021，15（4）：624-634.
[4] Hull RP，Goldsmith DJ. Nephrotic syndrome in adults [J]. BMJ，2008，336（7654）：1185-1189.
[5] 裘沛然，邓铁涛，王永炎.中华医典[M].5版.长沙：湖南电子音像出版社，2014.
[6] 孙思邈.备急千金要方[M].山西：山西科学技术出版社，2020.
[7] 李景荣.备急千金要方校释[M].北京：人民卫生出版社，1998.
[8] 李景荣.千金翼方校释[M].北京：人民卫生出版社，2014.
[9] 张璐.千金方衍义[M].北京：中医药出版社，1996.
[10] 国家药典委员会.中华人民共和国药典[S].一部.北京：中国医药科技出版，2020.
[11] 南京中医药大学.中药大辞典[M].上海：上海科学技术出版社，2018.
[12] 罗粤铭，翁衡，黄馨怡，等.基于数据挖掘的肾系水肿茯苓运用研究[J].世界科学技术-中医药现代化，2019， 21（10）：2159-2167.
[13] 黄佳蕙，黄馨怡，张蕾.基于古籍文献挖掘探索肾性水肿朝代用药特点[J].辽宁中医药大学学报，2021，23（9）：65-69.
[14] 胡馨予，杨宝怡，甘洁文.肾性水肿中医药治疗规律探究[J].深圳中西医结合杂志，2020，30（12）：56-58.
[15] 赵宇辉，唐丹丹，陈丹倩，等.利尿药茯苓、茯苓皮、猪苓和泽泻的化学成分及其利尿作用机制研究进展[J].中国药理学与毒理学杂志，2014，28（4）：594-599.
[16] 武士锋，赵菁莉，杨洪涛.杨洪涛教授运用附子温阳治疗慢性肾脏病的经验[J].中国中西医结合肾病杂志，2009， 10（11）：945-947.
[17] 冯喆，雷根平，董盛.NLRP3炎症小体在肾脏疾病中的作用机制与干预策略[J].暨南大学学报（自然科学与医学版），2021，42（5）：490-500.
[18] 李宁，白莉，苗明三.基于数据挖掘的中药防范炎症因子过度表达致“炎症风暴”用药规律分析[J].中药药理与临床，2020，36（2）：32-35.
[19] 王欢欢，郭琴，彭高强，等.基于古籍的生姜和干姜来源、功效及用法研究[J].长春中医药大学学报，2022，38（1）：17-21.
[20] 刘倩，韦衡秋，彭柳莹.甘遂泻水散结作用的研究进展[J].中外医学研究，2019，17（9）：184-186.
[21] 杨盛智，吕静.提壶揭盖法治疗肾性水肿的研究进展[J].实用中医内科杂志，2021，35（5）：37-39.
[22] 吴印亮，赵占领，陶晓华.浅议孙思邈辨治水肿病规律[J].中医学报，2018，33（1）：84-87.
[23] 汪义明，邓剑雅.“血不利则为水”理论阐发与研究概述[J].成都中医药大学学报，2021，44（2）：27-30.
[24] 尹玉祥，焦安钦.肾络瘀阻理论论治膜性肾病的研究探讨[J].中国中医药现代远程教育，2022，20（1）：89-91.
[25] 孙婧，杨燕云，许亮，等.鬼箭羽化学成分与药理作用研究进展[J].辽宁中医药大学学报，2021，23（7）：85-95.
[26] 郭延秀，席少阳，马毅，等.鬼箭羽化学成分及药理活性研究进展[J].中国现代应用药学，2021，38（18）：2305- 2316. |
|
|
|
